Cochrane authors on drug industry payroll should not be allowedPeter C Gøtzsche
11 April 2019
Angiotensin– neprilysin inhibitors: should we initiate them in hospital for patients with acute decompensated heart failure?Sam E. Grigg
9 September 2019
TAVR for low-risk severe aortic stenosis: is this the end of surgical valve replacement?Robert Thomas Harvey, Yash Singbal
1 November 2019
Cochrane vertebroplasty review misrepresented evidence for vertebroplasty with early intervention in severely affected patientsWilliam Clark, Paul Bird, Terrence Diamond, Peter Gonski, Val Gebski
9 March 2019
Evidence-based management as a basis for evidence-based medical consultationEdris Hasanpoor, Mohammadkarim Bahadori, Maryam Yaghoubi, Elaheh Haghgoshayie, Alireza Mahboub-Ahari
29 November 2018
Automatic extraction of quantitative data from ClinicalTrials.gov to conduct meta-analysesThomas R Fanshawe, Rafael Perera
17 July 2019
TIDieR checklist evaluation of clinical trial intervention reporting for recent FDA-approved anticancer medicationsCole Wayant, Richard Bindernagel, Matt Vassar
25 October 2019
Prevention of cardiovascular disease and renal failure in type 2 diabetes: sodium-glucose cotransporter-2 (SGLT2) inhibitorsJack W O’Sullivan
31 July 2019
Make quotations great again: a proposal to reduce false-knowledgeRonen Bareket, Mara A Schonberg, Yochai Schonmann
25 February 2019
The magnitude of small-study effects in the Cochrane Database of Systematic Reviews: an empirical study of nearly 30 000 meta-analysesLifeng Lin, Linyu Shi, Haitao Chu, Mohammad Hassan Murad
4 July 2019
